Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking

Trial Profile

Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Dec 2017

At a glance

  • Drugs Varenicline (Primary)
  • Indications Schizoaffective disorder; Schizophrenia; Smoking withdrawal
  • Focus Therapeutic Use
  • Acronyms SCRP
  • Most Recent Events

    • 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Jul 2008 Status changed from initiated to recruiting based on information from ClinicalTrials.gov.
    • 12 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top